Cash flow Sakar Healthcare Limited

Equities

SAKAR

INE732S01012

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 11:24:49 13/09/2024 BST			5-day change	1st Jan Change
339.30 ^INR	+2.11%		+4.93%	-15.19%

08-13	Sakar Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
05-21	Sakar Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

8ff3d6bff59ee1667ae983fbb9.-dOFgU_zfE_6su2OpA-fR7EQpgL81O3gDjm5IKEi6Lc.gZvK8GK0Pn6J4bn0_Tbyc9UolW2xuoiQYlfzdNRyksKxhuKsJbsWeqrBvA

Published financial data: SAKAR HEALTHCARE LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	830M	947M	1.28B	1.33B	1.53B
Other Revenues, Total	9.34M	5.72M	8.91M	8.33M	8.16M
Total Revenues	839M	953M	1.29B	1.34B	1.54B
Cost of Goods Sold, Total	437M	515M	749M	737M	842M
Gross Profit	402M	438M	542M	604M	700M
Selling General & Admin Expenses, Total	123M	133M	154M	169M	199M
Depreciation & Amortization - (IS)	70.8M	80.58M	96.67M	150M	181M
Other Operating Expenses	73.07M	73.23M	86.57M	94.1M	107M
Other Operating Expenses, Total	266M	287M	337M	413M	486M
Operating Income	136M	151M	206M	191M	214M
Interest Expense, Total	-21.12M	-23.34M	-25.88M	-54.88M	-67.45M
Interest And Investment Income	145K	163K	-	3.93M	1.25M
Net Interest Expenses	-20.97M	-23.17M	-25.88M	-50.95M	-66.2M
Currency Exchange Gains (Loss)	8.67M	5.85M	11.62M	34.49M	17.23M
Other Non Operating Income (Expenses)	-1.47M	-1.61M	-2.66M	-4.75M	-8.71M
EBT, Excl. Unusual Items	122M	132M	189M	170M	156M
Gain (Loss) On Sale Of Investments	-	-	623K	-	2.94M
Other Unusual Items	-	-	-	-51K	-
EBT, Incl. Unusual Items	122M	132M	189M	170M	159M
Income Tax Expense	26.04M	25.5M	37.52M	42.33M	42.29M
Earnings From Continuing Operations	96.23M	107M	152M	128M	117M
Net Income to Company	96.23M	107M	152M	128M	117M
Net Income - (IS)	96.23M	107M	152M	128M	117M
Net Income to Common Incl Extra Items	96.23M	107M	152M	128M	117M
Net Income to Common Excl. Extra Items	96.23M	107M	152M	128M	117M
Per Share Items
Net EPS - Basic	6.43	7.09	8.9	6.86	5.69
Basic EPS - Continuing Operations	6.43	7.09	8.9	6.86	5.69
Basic Weighted Average Shares Outstanding	14.96M	15.08M	17.05M	18.59M	20.52M
Net EPS - Diluted	6.43	7.09	8.9	6.86	5.69
Diluted EPS - Continuing Operations	6.43	7.09	8.9	6.86	5.69
Diluted Weighted Average Shares Outstanding	14.96M	15.08M	17.05M	18.59M	20.52M
Normalized Basic EPS	5.11	5.49	6.92	5.71	4.75
Normalized Diluted EPS	5.11	5.49	6.92	5.71	4.75
Supplemental Items
EBITDA	207M	232M	295M	341M	393M
EBITA	161M	177M	206M	191M	214M
EBIT	136M	151M	206M	191M	214M
Total Revenues (As Reported)	850M	959M	1.3B	1.38B	1.57B
Effective Tax Rate - (Ratio)	21.3	19.27	19.82	24.91	26.6
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	26.31M	31.78M	33.98M	0	0
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-274K	-6.27M	3.55M	41.18M	42.29M
Normalized Net Income	76.42M	82.7M	118M	106M	97.53M
Interest on Long-Term Debt	3.72M	-	-	-	-
Non-Cash Pension Expense	330K	486K	594K	0	0
Supplemental Operating Expense Items
Advertising Expense	24.78K	54.98K	223K	276K	65K
Marketing Expenses	1.26M	121K	1.14M	1.39M	716K
Selling and Marketing Expenses	1.29M	176K	1.36M	1.67M	781K
Research And Development Expense From Footnotes	16.33M	16.96M	-	6.06M	5.46M
Maintenance & Repair Expenses, Total	6.17M	4.1M	4.49M	1.98M	5.31M

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	2.96M	825K	299K	933K	2.58M
Short Term Investments	-	-	-	-	2.08M
Trading Asset Securities, Total	-	-	71.06M	34.29M	-
Total Cash And Short Term Investments	2.96M	825K	71.36M	35.23M	4.66M
Accounts Receivable, Total	82.34M	124M	142M	221M	209M
Other Receivables	-	-	-	-	100K
Notes Receivable	757K	-	-	-	-
Total Receivables	83.1M	124M	142M	221M	209M
Inventory	111M	158M	142M	154M	277M
Prepaid Expenses	755K	857K	2.23M	4.6M	8.44M
Other Current Assets, Total	19.13M	54.14M	143M	145M	216M
Total Current Assets	217M	337M	500M	559M	716M
Gross Property Plant And Equipment	844M	1.32B	2.29B	3.11B	3.69B
Accumulated Depreciation	-89.17M	-144M	-234M	-384M	-563M
Net Property Plant And Equipment	755M	1.17B	2.06B	2.73B	3.13B
Long-term Investments	100K	-	-	-	-
Other Intangibles, Total	32.8M	7.3M	-	-	14.57M
Loans Receivable Long-Term	-	-	8.13M	3.01M	3.01M
Other Long-Term Assets, Total	147M	260M	110M	70.29M	21.43M
Total Assets	1.15B	1.78B	2.68B	3.36B	3.89B
Liabilities
Accounts Payable, Total	46M	71.9M	305M	261M	275M
Accrued Expenses, Total	-	266K	470K	2.95M	1.95M
Short-term Borrowings	22.63M	16.92M	45.19M	130M	139M
Current Portion of Long-Term Debt	19.62M	24.55M	33.36M	79.33M	105M
Current Income Taxes Payable	15.55M	29.47M	31.26M	15.1M	12.36M
Other Current Liabilities	38.58M	190M	52.31M	56.49M	57.79M
Total Current Liabilities	142M	333M	468M	545M	591M
Long-Term Debt	125M	385M	850M	982M	550M
Pension & Other Post Retirement Benefits	6.98M	7.93M	14.38M	16.98M	22.88M
Deferred Tax Liability Non Current	63.96M	68.28M	70.93M	85.73M	100M
Total Liabilities	338M	793M	1.4B	1.63B	1.26B
Common Stock, Total	150M	156M	171M	190M	217M
Additional Paid In Capital	348M	421M	546M	860M	1.56B
Retained Earnings	310M	409M	559M	689M	805M
Comprehensive Income and Other	5.33M	-1.56M	-1.56M	-6.02M	40.91M
Total Common Equity	813M	985M	1.27B	1.73B	2.62B
Total Equity	813M	985M	1.27B	1.73B	2.62B
Total Liabilities And Equity	1.15B	1.78B	2.68B	3.36B	3.89B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	14.96M	15.62M	18.62M	19.04M	21.75M
ECS Total Common Shares Outstanding	14.96M	15.62M	17.12M	19.04M	21.75M
Book Value / Share	54.35	63.04	74.46	91.04	120.61
Tangible Book Value	780M	977M	1.27B	1.73B	2.61B
Tangible Book Value Per Share	52.16	62.57	74.46	91.04	119.94
Total Debt	167M	426M	929M	1.19B	794M
Net Debt	164M	425M	857M	1.16B	789M
Debt Equivalent of Unfunded Proj. Benefit Obligation	6.98M	8.2M	14.85M	20.4M	24.83M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	83.42M	122M	116M	125M	234M
Inventories - Finished Goods, Total	25.92M	34.98M	25.65M	29.22M	42.99M
Land - (BS)	53.36M	53.36M	53.36M	53.36M	182M
Buildings, Total	142M	170M	542M	575M	599M
Machinery, Total	518M	604M	1.68B	2.42B	2.91B
Full Time Employees	243	247	297	297	325
Accumulated Allowance for Doubtful Accounts (Supple)	58.38K	29.36K	-	-	146K

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	96.23M	107M	152M	128M	117M
Depreciation & Amortization - CF	46.25M	55.08M	89.37M	150M	180M
Amortization of Goodwill and Intangible Assets - (CF)	24.54M	25.5M	-	-	-
Depreciation & Amortization, Total	70.8M	80.58M	89.37M	150M	180M
Amortization of Deferred Charges, Total - (CF)	-	-	7.73M	576K	1.54M
(Gain) Loss on Sale of Investments - (CF)	-	-	-1.18M	-1.27M	2.94M
Provision and Write-off of Bad Debts	-	29.36K	-	-	-
Other Operating Activities, Total	19.37M	26.66M	68.38M	50.71M	-1.07B
Change In Accounts Receivable	12.69M	-41.43M	-18.18M	-79.09M	11.48M
Change In Inventories	-40.77M	-47.64M	15.14M	-12.14M	-123M
Change In Accounts Payable	14.51M	25.9M	107M	-44.16M	13.65M
Change in Other Net Operating Assets	-71.58M	-5.15M	-63.31M	141M	1.11B
Cash from Operations	101M	146M	357M	333M	245M
Capital Expenditure	-133M	-355M	-975M	-822M	-596M
Cash Acquisitions	-100K	-	-	-	-
Sale (Purchase) of Intangible assets	-3.56M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-70.93M	38.04M	31.35M
Other Investing Activities, Total	-	-113M	143M	40.15M	48.86M
Cash from Investing	-137M	-468M	-904M	-744M	-515M
Long-Term Debt Issued, Total	52.1M	261M	937M	132M	-
Total Debt Issued	52.1M	261M	937M	132M	-
Long-Term Debt Repaid, Total	-	-	-459M	-	-433M
Total Debt Repaid	-	-	-459M	-	-433M
Issuance of Common Stock	43.76K	78.84M	101M	334M	726M
Other Financing Activities, Total	-17.33M	-19.05M	-33.01M	-54.75M	-19.02M
Cash from Financing	34.81M	320M	546M	411M	274M
Miscellaneous Cash Flow Adjustments	-	-	-	1K	-1K
Net Change in Cash	-708K	-2.23M	-526K	635K	3.72M
Supplemental Items
Cash Interest Paid	17.33M	19.05M	28.97M	54.17M	66.45M
Cash Income Tax Paid (Refund)	27.72M	7.26M	-1.78M	42.66M	1.17B
Levered Free Cash Flow	9.6M	-127M	-760M	-735M	-499M
Unlevered Free Cash Flow	22.8M	-113M	-745M	-701M	-458M
Change In Net Working Capital	-3.64M	-67.49M	-5.38M	149M	176M
Net Debt Issued / Repaid	52.1M	261M	478M	132M	-433M

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	8	6.46	5.77	3.96	3.68
Return on Total Capital	9.4	7.91	7.11	4.66	4.21
Return On Equity %	12.57	11.88	13.44	8.48	5.36
Return on Common Equity	12.57	11.88	13.44	8.48	5.36
Margin Analysis
Gross Profit Margin %	47.96	45.94	42.01	45.05	45.38
SG&A Margin	14.61	13.94	11.89	12.62	12.88
EBITDA Margin %	24.65	24.32	22.85	25.41	25.51
EBITA Margin %	19.14	18.55	15.92	14.25	13.86
EBIT Margin %	16.21	15.87	15.92	14.25	13.86
Income From Continuing Operations Margin %	11.47	11.21	11.76	9.51	7.57
Net Income Margin %	11.47	11.21	11.76	9.51	7.57
Net Avail. For Common Margin %	11.47	11.21	11.76	9.51	7.57
Normalized Net Income Margin	9.11	8.68	9.13	7.92	6.33
Levered Free Cash Flow Margin	1.14	-13.37	-58.9	-54.79	-32.39
Unlevered Free Cash Flow Margin	2.72	-11.84	-57.68	-52.27	-29.7
Asset Turnover
Asset Turnover	0.79	0.65	0.58	0.44	0.43
Fixed Assets Turnover	1.18	0.99	0.8	0.56	0.53
Receivables Turnover (Average Receivables)	9.36	9.19	9.66	7.36	7.13
Inventory Turnover (Average Inventory)	4.86	3.84	5.01	4.99	3.9
Short Term Liquidity
Current Ratio	1.52	1.01	1.07	1.03	1.21
Quick Ratio	0.6	0.37	0.46	0.47	0.36
Operating Cash Flow to Current Liabilities	0.71	0.44	0.76	0.61	0.41
Days Sales Outstanding (Average Receivables)	39.12	39.7	37.8	49.62	51.3
Days Outstanding Inventory (Average Inventory)	75.29	95.02	72.83	73.21	93.73
Average Days Payable Outstanding	30.93	38.27	125.09	137.78	101.49
Cash Conversion Cycle (Average Days)	83.48	96.45	-14.46	-14.96	43.54
Long Term Solvency
Total Debt/Equity	20.53	43.27	72.85	68.75	30.25
Total Debt / Total Capital	17.04	30.2	42.15	40.74	23.22
LT Debt/Equity	15.34	39.05	66.69	56.67	20.95
Long-Term Debt / Total Capital	12.72	27.26	38.58	33.58	16.08
Total Liabilities / Total Assets	29.36	44.63	52.4	48.46	32.5
EBIT / Interest Expense	6.44	6.48	7.95	3.48	3.17
EBITDA / Interest Expense	9.79	9.93	11.4	6.21	5.83
(EBITDA - Capex) / Interest Expense	3.49	-5.3	-26.29	-8.76	-3
Total Debt / EBITDA	0.81	1.84	3.15	3.49	2.02
Net Debt / EBITDA	0.79	1.83	2.91	3.39	2.01
Total Debt / (EBITDA - Capex)	2.26	-3.45	-1.36	-2.48	-3.92
Net Debt / (EBITDA - Capex)	2.22	-3.44	-1.26	-2.4	-3.9
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	21.95	13.58	35.47	3.93	14.89
Gross Profit, 1 Yr. Growth %	21.13	9.01	23.69	11.44	15.74
EBITDA, 1 Yr. Growth %	18.7	12.09	42.96	21.94	15.32
EBITA, 1 Yr. Growth %	22.27	10.07	35.94	-7.37	11.8
EBIT, 1 Yr. Growth %	19.49	11.18	35.94	-7.37	11.8
Earnings From Cont. Operations, 1 Yr. Growth %